
Publication Frequency
Quarterly since 2025
Journal Articles
Search
Search scope
Journal Center
Asia Pacific Academy of Science Pte. Ltd. (APACSCI) specializes in international journal publishing. APACSCI adopts the open access publishing model and provides an important communication bridge for academic groups whose interest fields include engineering, technology, medicine, computer, mathematics, agriculture and forestry, and environment.
Volume Arrangement
2025
Featured Articles

Psoriasis is a common, chronic, and inflammatory skin disease. Macrophages account for about 61.3% of the inflammatory cells infiltrating psoriatic lesions. Modulating macrophage polarization, inhibiting their infiltration, and targeting the secretion of inflammatory factors and associated inflammatory pathways by these cells can alleviate psoriasis symptoms and inflammation. Moreover, nanomaterials as novel drug carriers, offer unique advantages such as large surface area, easy modification, high biocompatibility, good biodegradability, enhanced systemic adsorption, etc. Nanomaterials have great potential for efficient drug delivery and release, as well as improving therapeutic efficacy while reducing adverse effects. By systematically addressing the role of macrophages in psoriasis pathogenesis and the potential of nanomaterials in treating psoriasis through modulating macrophages, this review enhances our understanding of the disease mechanism and holds promise for novel therapeutic breakthroughs and advancements in the future treatment of psoriasis.
Interaction between miR-140 and HDAC4 in Gastric Cancer Metastasis
Article ID: 3506
Vol 39, Issue 1, 2025
DOI: https://doi.org/10.23812/j.biol.regul.homeost.agents.20253901.7
Vol 39, Issue 1, 2025
Download PDF
Abstract
Background: miRNAs are involved in the process of tumorigenesis and metastasis as tumor suppressor genes or oncogenes. This
work aims to explore the effect of miR-140 in the proliferation and invasion as well as metastasis of gastric cancer cells, as well
as to provide new target for the diagnosis and therapy for gastric cancer.
Methods: miR-140 mimics and miR-140 inhibitors were transfected to the SGC-7901 gastric cancer cells, the expression of miR-
140 and histone deacetylase4 (HDAC4) in human gastric cancer and normal gastric tissues was evaluated by quantitative reverse
transcription-PCR (qRT-PCR), the HDAC4 protein level was evaluated by western blot method. The effects of miR-140 upregulation and downregulation on the invasion and metastasis ability of SGC-7901 cells were investigated by Transwell cell model.
The samples were classified into control group by adding lipofectamine 2000, negative control group by adding miRNA unrelated
sequence and lipofectamine 2000, miRNA up-regulated transfection group by adding miR-140 mimics and lipofectamine 2000
were added, as well as miRNA down-regulated transfection group by adding miR-140 inhibitors and lipofectamine 2000.
Results: The effects of up and down regulation of miR-140 on the invasion and metastasis ability of SGC-7901 cells were determined by Transwell chamber model. The expression of miR-140 in gastric cancer cells was significantly lower than that of normal
gastric tissue (p < 0.05). The invasion and metastasis ability of SGC-7901 cells in miR-140 mimics and miR-140 inhibitor groups
were significantly lower and higher when compared with negative control (NC) and control groups, respectively. HDAC protein
was significant up-expressed in miR-140 inhibitor group when compared with NC and control groups. All these differences were
of statistical significance (p < 0.05).
Conclusion: The expression level of miR-140 are associated with the invasive and metastatic properties of gastric cancer cells,
which may serve as new target for the clinical treatment of gastric cancer.
Keywords
gastric cancer; miR-140; HDAC4; SGC-7901; invasion; metastasis
References
1.
Refbacks
- There are currently no refbacks.
Copyright (c) 2025 Yiwei Zhang, Shaoqing Wang,Feng Gao,Xiaoying Wang,Yurong Sun,Xianyan Wang

This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
Editor-in-Chief

Medical Genetics, University of Torino Medical School, Italy
Co-Editor-in-Chief

Department of Biomedical, Surgical and Dental Sciences, University of Milan, Italy
Indexing & Archiving
-
-
-
Scopus (CiteScore: 2.2)
-
-
News & Announcements
2025-02-01
In addition to the first issue that has already been published by the original publisher, there will be four more issues released this year, with scheduled publication dates in March, June, September, and December respectively.
2025-01-21
Starting from Volume 39 Issue 2 (2025), the ownership of Journal of Biological Regulators and Homeostatic Agents (ISSN: 0393-974X (P); 1724-6083 (O)) will be transferred from Biolife Sas to Asia Pacific Academy of Science Pte. Ltd. As of 21 January 2025, authors should make submissions to the new journal system and follow the author guidelines. Asia Pacific Academy of Science Pte. Ltd. will take over the publication of manuscripts being processed.